Research Paper Volume 15, Issue 16 pp 8204—8219
PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
Figure 4. Development of nomograms for the PFS and OS of NSCLC with ICIs. (A) Systematic nomogram to predict the 6-month and 1-year PFS. (B) Systematic nomogram to predict the 1-year and 3-year OS. (C) The calibration plot for the chance of surviving 6-month and 1-year PFS. (D) The calibration plot for the chance of surviving 1-year and 3-year OS. (E) The ROC curve for the chance of 6-month and 1-year PFS. (F) The ROC curve for the chance of 6-month and 1-year PFS.